Pharmaceutical Technology

JULY 7, 2022

There is a lot of excitement that we could be at the start of a new era for the biopharmaceutical industry, with the hope of delivering revolutionary healthcare for previously unaddressed diseases finally becoming a reality. A new frontier in cancer research. Securing the supply chain. The industry is moving at an unprecedented speed.

FDA 98

FDA 98

European Pharmaceutical Review

OCTOBER 26, 2023

In August 2023, Biswajit Podder, PhD, Oncology and Hematology Analyst at GlobalData shared that HER2-positive breast cancer “seems to be a major focus” in ADC drug development. Podder continued, highlighting however that the current challenges of ADCs include drug resistance and their complex and costly manufacturing processes.

Chemotherapy 91

Chemotherapy 91

PharmaShots

MAY 24, 2023

The chart depicts data till 10th May 2023) Product Dashboard PharmaShots has created a product dashboard that presents key metrics and data on Trikafta/Kaftrio in a visual format. The cost may limit its availability in certain healthcare systems and regions, creating disparities in access. independent.co.uk cysticfibrosis.ca

Insurance Coverage 56

Insurance Coverage FDA Hospitals Dosage 56

Pharmaceutical Technology

JUNE 23, 2022

The global healthcare and pharmaceutical industry is frequently faced with having to find new ways of innovating and carrying out its work in order to overcome tragic circumstances that will typically come with a huge human cost. In 2021,18% of all trials adopted a decentralised component, according to research by GlobalData.

Customer Service 52

Customer Service Hospitals Vaccines Communication 52

Pharmaceutical Technology

NOVEMBER 9, 2022

According to a recent GlobalData report, healthcare professionals have – for the second year in a row – ranked artificial intelligence (AI) and Big Data as the top two technologies revolutionising the pharmaceutical sector. AI modelling pre-empts supply chain shocks and tests possible solutions.

Vaccines 52

Vaccines Packaging Communication 52

Pharmaceutical Technology

JULY 29, 2022

Mikael Dolsten, Pfizer’s chief scientific officer, told Goldman Sachs’ 43rd Annual Global Healthcare Conference on 15 June: “The upgraded vaccine is about two weeks from now. Pfizer completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted bivalent Covid-19 vaccine candidate, based on the BA.1

Vaccines 52

Vaccines Packaging Immunization FDA 52

Pharmaceutical Technology

AUGUST 8, 2022

There’s no dearth of interest, however, in applying digital solutions to healthcare. Privacy concerns present but variable. The digital pill, now marketed by Otsuka Pharmaceuticals, is forecasted to make $27 million in sales in 2022, as per GlobalData. GlobalData is the parent company of Pharmaceutical Technology.

FDA 122

FDA Hospitals 122

Pharmaceutical Technology

MARCH 17, 2023

These agreements have been particularly propelled by the recent rise in inflationary pressures and pharmaceutical market instability, pushing healthcare systems to find new ways to reduce risks associated with new drugs. GlobalData is the parent company of Pharmaceutical Technology. global growth for the year ahead.

Pharmaceutical Companies 102

Pharmaceutical Companies Pharmaceutical Companies Communication 102

Pharmaceutical Technology

MARCH 20, 2023

Source: GlobalData. In the fourth quarter of 2022, the most recent period for which data is available, GlobalData estimates suggest the value of venture capital investment in pharmaceutical firms worldwide was $7.8 Source: GlobalData. Source: GlobalData. Source: GlobalData. That is a fall of 32.5%

Vaccines 90

Vaccines Communication Hospitals 90

Pharmaceutical Technology

MAY 4, 2023

Cases of nontuberculous mycobacteria (NTM) infections are growing globally, presenting numerous challenges for healthcare facilities in keeping vulnerable patients safe. While Pseudomonas and Legionella present considerable challenges, they are easier to detect and treat than NTM.

Hospitals 52

Hospitals Documentation Communication Immunization 52

Pharmaceutical Technology

APRIL 4, 2023

million) in the latest extension round, which was led by Pontifax Venture Capital, and existing investors Novo Holdings and Ysios Capital, along with RA Capital Management, HealthCap and Gilde Healthcare. GlobalData is the parent company of Pharmaceutical Technology. Adcendo then went on to raise the additional €31 million ($33.9

Immunization 52

Immunization Communication 52

Pharmaceutical Technology

JUNE 22, 2023

Presented as part of the EC’s long-awaited pharmaceutical reform in late April, the scheme aims to encourage the research of novel antimicrobials by creating a system of transferable exclusivity vouchers. But there are still many unknowns at that point, which presents some risk for a company here, notes Årdal.

Documentation 52

Documentation Communication 52

Pharmaceutical Technology

MAY 26, 2023

In a warning letter for a website distributing stimulants including amphetamines, the FDA highlighted that these websites pose a “significant risk” to US customers as stimulant medications present a high risk for potential abuse. Eckel says that pharmacists have been hit by the repercussions of efforts to make healthcare cheaper. “In

FDA 52

FDA Adverse Reactions Insurance Communication 52

Pharmaceutical Technology

MARCH 23, 2023

As per GlobalData, practitioners typically turn to five drugs to treat PCOS ; the main drug is metformin, accounting for almost a quarter of trials (24.7%). GlobalData is the parent company of Pharmaceutical Technology. Hormonal contraceptives, and other drugs like clomiphene, eflornithine have been reported to ameliorate symptoms.

Communication 52

Communication 52

Pharmaceutical Technology

JANUARY 16, 2023

Authorities in some European capitals—one prominent example being Denmark—are poised to embark on multiyear price cap negotiations with the innovative pharmaceutical industry, where the present inflationary climate will likely have a complicated influence on any final deal. What is the Global Healthcare and Pharma Market Q2 Outlook?

Pharmaceutical Companies 64

Pharmaceutical Companies Pharmaceutical Companies Communication Hospitals 64

Pharmaceutical Technology

JANUARY 16, 2023

Authorities in some European capitals—one prominent example being Denmark—are poised to embark on multiyear price cap negotiations with the innovative pharmaceutical industry, where the present inflationary climate will likely have a complicated influence on any final deal. What is the Global Healthcare and Pharma Market Q2 Outlook?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Hospitals 52

Pharmaceutical Technology

JANUARY 5, 2023

What is the Global Healthcare and Pharma Market Q2 Outlook? GlobalData’s World Markets Healthcare (WMH) service has released its latest Q2 forecast. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies. By GlobalData. Free Report. Antarctica.

Vaccines 69

Vaccines Labelling Communication 69

Pharmaceutical Technology

FEBRUARY 20, 2023

A 2022 report published by GlobalData found that in analysis of 12,698 clinical trials initiated over nine and a half years to June 2022 racial minority representation in pivotal studies is extremely low, accounting for 23.9% This may sound obvious, but it is still a major hurdle in drug development. of the clinical trial population globally.

Vaccines 52

Vaccines Communication Immunization 52

Pharmaceutical Technology

JANUARY 25, 2023

Morgan Healthcare Conference in San Francisco, which finished on January 12. Inflation affects net present value (NPV) models used by biotech companies, given that they are a decade away from potential revenue, says Jack O’Meara, CEO of the biotech Ochre Bio. In 2022, another partnership between AbbVie and Morphic was also dropped.

Communication 69

Communication 69